专题：Breast Cancer Treatment Studies

This cluster of papers focuses on molecular research, treatment response, and prognostic markers in breast cancer. It covers topics such as gene expression patterns, molecular subtypes, neoadjuvant therapy, radiotherapy, and the impact of hormone receptors on survival. The papers also discuss the development of clinical practice guidelines for breast cancer management.
最新文献
Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women

article Full Text OpenAlex

Predicting occult lymph node metastasis in level II using preoperative factors

article Full Text OpenAlex

The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate our Former Strategy?

article Full Text OpenAlex

The significance of molecular heterogeneity in breast cancer batch correction and dataset integration

article Full Text OpenAlex

Ovarian Function Suppression in HR-Positive, HER2-Positive Breast Cancer: An Exploratory Analysis of the HERA Trial

article Full Text OpenAlex

Postoperative Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer With GammaPod Technology: A Phase 2 Clinical Trial

article Full Text OpenAlex

Identify high-risk patients of T1–2N1M0 breast cancer who benefit from postmastectomy radiotherapy: a dual-center retrospective propensity score-matched study

article Full Text OpenAlex

Health economic outcomes and costs of CDK4/6 inhibitor use in first- versus second-line for advanced breast cancer: A cost-effectiveness analysis of the phase 3 SONIA trial

article Full Text OpenAlex

Development of Size-Tunable Superparamagnetic Iron Oxide/Fluorescent Conjugated Polymer Composite Nanoparticles for Sentinel Lymph Node Biopsy

article Full Text OpenAlex

American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions

article Full Text OpenAlex

近5年高被引文献
Breast Cancer Statistics, 2022

article Full Text OpenAlex 2251 FWCI325.1899295

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer

article Full Text OpenAlex 1015 FWCI135.82055936

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

article Full Text OpenAlex 925 FWCI123.58447293

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

article Full Text OpenAlex 917 FWCI118.82599487

Triple negative breast cancer: Pitfalls and progress

review Full Text OpenAlex 630 FWCI86.19643106

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer

article Full Text OpenAlex 628 FWCI126.62726822

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 626 FWCI139.3382529

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial

article Full Text OpenAlex 603 FWCI121.29990743

Pathogenesis of Triple-Negative Breast Cancer

review Full Text OpenAlex 574 FWCI76.95138799

[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures

review Full Text OpenAlex 524 FWCI132.77174335